Phagos

French tech company | Builders Republic

About

Biotech developing personalized bacteriophage therapies as an alternative to antibiotics for livestock — chicken, cattle, swine and shrimp — using a platform that combines microbiology and AI to identify which phages kill a given bacterial strain, then delivers treatments dissolved in drinking water. Holds EU marketing authorization for veterinary phage products.

Key facts

Status
Active
Sectors
Agrifood
Latest stage
Series A
Founded
2021
City
SAINT-MANDE
Region
IDF
Tracked rounds
2
Amount raised
27 M€ raised since 2020

Funding rounds

  • Series A — 2025
  • Seed — 2022

Investors